Journal
Cell
Publication Date
2-20-2020
Volume
180
Issue
4
First Page
729
Last Page
748
Document Type
Open Access Publication
DOI
10.1016/j.cell.2020.01.026
Rights and Permissions
Dou Y, Kawaler EA, Cui Zhou D, Gritsenko MA, Huang C, Blumenberg L, Karpova A, Petyuk VA, Savage SR, Satpathy S, Liu W, Wu Y, Tsai CF, Wen B, Li Z, Cao S, Moon J, Shi Z, Cornwell M, Wyczalkowski MA, Chu RK, Vasaikar S, Zhou H, Gao Q, Moore RJ, Li K, Sethuraman S, Monroe ME, Zhao R, Heiman D, Krug K, Clauser K, Kothadia R, Maruvka Y, Pico AR, Oliphant AE, Hoskins EL, Pugh SL, Beecroft SJI, Adams DW, Jarman JC, Kong A, Chang HY, Reva B, Liao Y, Rykunov D, Colaprico A, Chen XS, Czekański A, Jędryka M, Matkowski R, Wiznerowicz M, Hiltke T, Boja E, Kinsinger CR, Mesri M, Robles AI, Rodriguez H, Mutch D, Fuh K, Ellis MJ, DeLair D, Thiagarajan M, Mani DR, Getz G, Noble M, Nesvizhskii AI, Wang P, Anderson ML, Levine DA, Smith RD, Payne SH, Ruggles KV, Rodland KD, Ding L, Zhang B, Liu T, Fenyö D; Clinical Proteomic Tumor Analysis Consortium. Proteogenomic Characterization of Endometrial Carcinoma. Cell. 2020 Feb 20;180(4):729-748.e26. doi.org/10.1016/j.cell.2020.01.026. This is an open access article distributed under the terms of the Creative Commons CC-BY license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Recommended Citation
Dou, Yongchao; Cui Zhou, Daniel; Karpova, Alla; Wu, Yige; Cao, Song; Wyczalkowski, Matthew A; Gao, Qingsong; Sethuraman, Sunantha; Mutch, David; Fuh, Katherine; Ding, Li; and et al, "Proteogenomic characterization of endometrial carcinoma." Cell. 180, 4. 729 - 748. (2020).
https://digitalcommons.wustl.edu/open_access_pubs/11945
Table S1. Meta Table Containing Genotype, Clinical, and Pathological Characteristics of Tumor Samples, Related to STAR Methods
mmc2.xlsx (132977 kB)
Table S2. Matrices of Gene Expression, Protein Abundance, Methylation, CNV, and Site-Level Mutation, Related to STAR Methods
mmc3.xlsx (141 kB)
Table S3. MSI Status Determination, Significantly Differentially Expressed Genes, and Somatic Mutations for Adjacent Tissues, Related to Figure 1
mmc4.xlsx (44 kB)
Table S4. Somatic Coding Variants with Proteomics Evidence and Novel Splice Junctions, Related to STAR Methods
mmc5.xlsx (1115 kB)
Table S5. SCNA Hotspots with Significant Trans Effects and circRNA and RNA Binding Protein Correlations, Related to Figures 4 and 5
mmc6.xlsx (13721 kB)
Table S6. Proteomic, PTM, and Transcriptomic Differential Abundance between Phenotypes and FDA-Approved Drugs for Candidate Genes, Related to Figure 6
mmc7.xlsx (125 kB)
Table S7. Predicted Neoantigens, APM-Based Subtypes, and Immune Scores, Related to Figure 7
